Intensity raises $10M in series A

Intensity Therapeutics Inc. (Westport, Conn.) said it raised $10 million in an oversubscribed series A financing from Batterson Venture Capital, VCapital, FastForward Innovations, SalvaRx Group, Declan Doogan and Jim Mellon, plus other undisclosed investors including family offices.

Intensity's intratumorally delivered formulations of existing chemotherapies are designed to have stronger efficacy than systemic chemo (see BioCentury, Feb. 10, 2014). ...